28Oct 2023
Effectiveness of the quadrivalent live attenuated influenza vaccine against influenza-related hospitalisations and morbidity among children aged 2 to 6 years in Denmark

Effectiveness of the quadrivalent live attenuated influenza vaccine against influenza-related hospitalisations and morbidity among children aged 2 to 6 years in Denmark

A Danish study investigated the real-world effectiveness of quadrivalent live attenuated influenza vaccines (LAIV-4) in children aged 2-6 years. Conducted during the 2021-2022 flu season, the study found that LAIV-4 significantly reduced influenza-related hospital contacts by 64.3% compared to non-vaccinated counterparts. However, it showed only a moderate reduction of 36.9% in influenza-related hospital admissions. The vaccine did not significantly impact admission rates for respiratory tract infections, wheezing or asthma, or antibiotic prescriptions. The study emphasizes the moderate effectiveness of LAIV-4 in preventing severe influenza outcomes in younger children, aligning with trial evidence.

  • #pediatrics

Like

Save

Share